ATE328280T1 - Verfahren und zusammensetzungen zur karzinomdiagnose - Google Patents

Verfahren und zusammensetzungen zur karzinomdiagnose

Info

Publication number
ATE328280T1
ATE328280T1 AT00908795T AT00908795T ATE328280T1 AT E328280 T1 ATE328280 T1 AT E328280T1 AT 00908795 T AT00908795 T AT 00908795T AT 00908795 T AT00908795 T AT 00908795T AT E328280 T1 ATE328280 T1 AT E328280T1
Authority
AT
Austria
Prior art keywords
mra
compositions
methods
mesothelin
subject
Prior art date
Application number
AT00908795T
Other languages
English (en)
Inventor
Nathalie B Scholler
Ingegerd Hellstrom
Karl Erik Hellstrom
Original Assignee
Pacific Northwest Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pacific Northwest Res Inst filed Critical Pacific Northwest Res Inst
Application granted granted Critical
Publication of ATE328280T1 publication Critical patent/ATE328280T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00908795T 1999-02-26 2000-02-25 Verfahren und zusammensetzungen zur karzinomdiagnose ATE328280T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12176799P 1999-02-26 1999-02-26
US14740499P 1999-08-05 1999-08-05

Publications (1)

Publication Number Publication Date
ATE328280T1 true ATE328280T1 (de) 2006-06-15

Family

ID=26819780

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00908795T ATE328280T1 (de) 1999-02-26 2000-02-25 Verfahren und zusammensetzungen zur karzinomdiagnose

Country Status (8)

Country Link
EP (1) EP1169645B1 (de)
JP (3) JP4813661B2 (de)
AT (1) ATE328280T1 (de)
AU (1) AU3007200A (de)
CA (1) CA2369433A1 (de)
DE (1) DE60028361T2 (de)
ES (1) ES2269105T3 (de)
WO (1) WO2000050900A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7030219B2 (en) 2000-04-28 2006-04-18 Johns Hopkins University B7-DC, Dendritic cell co-stimulatory molecules
US7270960B2 (en) * 2001-08-29 2007-09-18 Pacific Northwest Research Institute Diagnosis of ovarian carcinomas
WO2004006837A2 (en) 2002-07-12 2004-01-22 The Johns Hopkins University Mesothelin vaccines and model systems
US9200036B2 (en) 2002-07-12 2015-12-01 The Johns Hopkins University Mesothelin vaccines and model systems
US20090110702A1 (en) 2002-07-12 2009-04-30 The Johns Hopkins University Mesothelin Vaccines and Model Systems and Control of Tumors
US20040180387A1 (en) * 2003-03-13 2004-09-16 Fujirebio Diagnostics, Inc. Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of ovarian cancer
JP2007525971A (ja) * 2003-08-05 2007-09-13 モルフォテック、インク． 癌に関連する変異体細胞表面分子
US20060014221A1 (en) * 2004-01-21 2006-01-19 Fujirebio Diagnostics, Inc. Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of mesothelioma
WO2005072341A2 (en) * 2004-01-21 2005-08-11 Fujirebio America, Inc. Detection of mesothelin-/megakaryocyte potentiating factor-related peptides in peritoneal fluid for assessment of the peritoneum and the peritoneal cavity
JP5221381B2 (ja) 2006-01-04 2013-06-26 フジレビオ アメリカ、インク． 卵巣癌を判定するためのｈｅ４及び他の生化学マーカーの使用
JP5207437B2 (ja) * 2006-06-27 2013-06-12 独立行政法人理化学研究所 中皮由来組織特異的マーカーの同定及び検出方法
PL2195017T3 (pl) 2007-10-01 2015-03-31 Bristol Myers Squibb Co Ludzkie antyciała, które wiążą mezotelinę i ich zastosowania
US9023351B2 (en) * 2007-11-26 2015-05-05 Bayer Intellectual Property Gmbh Anti-mesothelin antibodies and uses thereof
US8481297B2 (en) 2009-01-08 2013-07-09 Yale University Compositions and methods of use of an oncolytic vesicular stomatitis virus
UY32560A (es) 2009-04-29 2010-11-30 Bayer Schering Pharma Ag Inmunoconjugados de antimesotelina y usos de los mismos
WO2011032003A1 (en) 2009-09-10 2011-03-17 Yale University Immunization to reduce neurotoxicity during treatment with cytolytic viruses
WO2011056993A1 (en) 2009-11-04 2011-05-12 Yale University Compositions and methods for treating cancer with attenuated oncolytic viruses
WO2015058111A1 (en) 2013-10-17 2015-04-23 The Brigham And Women's Hospital, Inc. Cationic nanoparticles for co-delivery of nucleic acids and thereapeutic agents
WO2015172153A1 (en) 2014-05-09 2015-11-12 Yale University Topical formulation of hyperbranched polyglycerol-coated particles thereof
US11918695B2 (en) 2014-05-09 2024-03-05 Yale University Topical formulation of hyperbranched polymer-coated particles
US20180126014A1 (en) 2015-04-15 2018-05-10 Yale University Compositions for enhancing delivery of agents across the blood brain barrier and methods of use thereof
WO2017095751A1 (en) 2015-12-02 2017-06-08 Partikula Llc Compositions and methods for modulating cancer cell metabolism
US20190117799A1 (en) 2016-04-01 2019-04-25 The Brigham And Women's Hospital, Inc. Stimuli-responsive nanoparticles for biomedical applications
CN106248767B (zh) * 2016-07-15 2018-12-07 济南大学 一种用于检测癌细胞中h2s的三维纸分析器件的制备方法
EP3512563A1 (de) 2016-09-16 2019-07-24 The Johns Hopkins University Protein-nanocages mit verbesserter schleimpenetration zur gezielten gewebe- und intrazellulären verabreichung
WO2018112470A1 (en) 2016-12-16 2018-06-21 The Brigham And Women's Hospital, Inc. Co-delivery of nucleic acids for simultaneous suppression and expression of target genes
EP3615052B1 (de) 2017-04-27 2023-01-25 The University of Hong Kong Verwendung von hcn-inhibitoren zur behandlung von krebs
WO2018237109A1 (en) 2017-06-23 2018-12-27 Yale University NANOMATERIALS HAVING IMPROVED MEDICATION DELIVERY EFFICIENCY
EP4377338A2 (de) 2021-07-27 2024-06-05 Novab, Inc. Manipulierte vlrb-antikörper mit immuneffektorfunktionen
WO2023147552A1 (en) 2022-01-28 2023-08-03 University Of Georgia Research Foundation, Inc. Radiosensitizing compositions and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2121792T3 (es) * 1990-10-12 1998-12-16 Us Health Anticuerpo monoclonal.
IL107366A (en) * 1992-10-23 2003-03-12 Chugai Pharmaceutical Co Ltd Genes coding for megakaryocyte potentiator
EP0871492B1 (de) * 1996-01-05 2003-11-26 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services Mesothelinantigen, verfahren und testsatz zur targetierung

Also Published As

Publication number Publication date
EP1169645B1 (de) 2006-05-31
DE60028361D1 (de) 2006-07-06
JP2010096774A (ja) 2010-04-30
JP4813661B2 (ja) 2011-11-09
JP2002538434A (ja) 2002-11-12
ES2269105T3 (es) 2007-04-01
WO2000050900A3 (en) 2001-08-23
WO2000050900A2 (en) 2000-08-31
DE60028361T2 (de) 2007-05-10
JP2011206062A (ja) 2011-10-20
CA2369433A1 (en) 2000-08-31
AU3007200A (en) 2000-09-14
EP1169645A2 (de) 2002-01-09

Similar Documents

Publication Publication Date Title
ATE328280T1 (de) Verfahren und zusammensetzungen zur karzinomdiagnose
CN102695716B (zh) 肝病病情指标糖链标记物
ATE426167T1 (de) Auto-antikírper gegen annexin-proteine als marker fur lungenkrebs
RU2004109149A (ru) Диагностика карцином
JP2011524013A (ja) 大麻の使用の検出
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
ATE554106T1 (de) Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
CN109406778A (zh) 一种检测烟叶中青枯病菌的时间分辨荧光定量试纸条及其制备方法和应用
EP0970377B1 (de) Diagnose von epithelzellabnormitäten
WO2006004958A3 (en) Detection or measurement of antibodies to antigenic proteins in biological tissues or samples
JP2004323508A (ja) 抗重金属モノクローナル抗体およびその使用方法
ATE433463T1 (de) Monospezifische antikörper gegen fibrinogen und fibrinopeptide b
CN106119340B (zh) 一种脱‑γ‑羧基凝血酶原的检测方法、检测试剂和检测试剂盒
ES2168310T3 (es) Reactivos y metodos de deteccion y de cuantificacion de la testosterona en muestras de fluido.
CN108333361A (zh) 桥连有抗体的磁性微球复合制剂及其制备方法与应用
CN108603883A (zh) 前列腺癌的判定方法
CN113880948B (zh) 抗ca724抗体或其抗原结合片段及其制备方法和应用
ATE432469T1 (de) Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebs
BR9815090A (pt) "moléculas de ácido nucléico correlacionadas com o fenótipo rhesus d fraco"
WO2002033084A3 (en) Identification of the dombrock blood group glycoprotein as a polymorphic member of the adp-ribosyltransferase gene family
SE0202702L (sv) Immunotest för specifik bestämning av SCCA isoformer
JPWO2006112482A1 (ja) Ｃ型肝炎ウイルス感染に関連する肝疾患の予後の予測
KR100737186B1 (ko) 항-에스트리올 항혈청을 포함하는 에스트리올 검출용바이오센서 및 에스트리올 검출방법
WO2004112694A3 (en) Immunogenic reagents from west nile virus
DE60131962D1 (de) Verfahren und zusammensetzungen zum nachweis von taenia solium larven mittels eines klonierten antigens

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties